| STV1 |
Saccharomyces cerevisiae |
|
STV1 is differentially expressed in 13 experiments [16 up/18 dn]: 3 compound treatments: none [0 up/2 dn], doxycycline [1 up/0 dn], ...; 1 clinical infos: respiratory deficient [0 up/1 dn], 2 developmental stages, 7 genotypes, 11 growth conditions and 2 other conditions. |
| STV1, YM9796.07, YMR054W |
|
ATP6V0A2 (Homo sapiens)
TCIRG1 (Homo sapiens)
ATP6V0A4 (Homo sapiens)
ATP6V0A1 (Homo sapiens)
vha-6 (Caenorhabditis elegans)
CG7678 (Drosophila melanogaster)
CG12602 (Drosophila melanogaster)
Vha100-2 (Drosophila melanogaster)
Vha100-3 (Drosophila melanogaster)
vha-5 (Caenorhabditis elegans)
NP_954520.2 (Rattus norvegicus)
vha-7 (Caenorhabditis elegans)
unc-32 (Caenorhabditis elegans)
NP_001100061.1 (Rattus norvegicus)
TECT2_RAT (Rattus norvegicus)
Atp6v0a4 (Mus musculus)
Atp6v0a2 (Mus musculus)
Atp6v0a1 (Mus musculus)
Tcirg1 (Mus musculus)
zgc:55891 (Danio rerio)
(Compare orthologs)
|
|
|
| ATPase, V0/A0 complex, 116kDa subunit |
|
|
| Golgi apparatus, integral to membrane, late endosome, proton-transporting ATPase activity, rotational mechanism, vacuolar proton-transporting V-type ATPase, V0 domain |
|
|
|
P37296
|
|
|
|
YMR054W
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Control
|
Growth condition |
|
|
50% dessication
|
Growth condition |
|
|
None
|
Compound treatment |
|
|
Wild_type
|
Genotype |
|
|
Doxycycline
|
Compound treatment |
|
|
Mitotic growth
|
Developmental stage |
|
|
Meiotic development
|
Developmental stage |
|
|
Abf1-1 hypomorph, homozygous
|
Genotype |
|
|
TetO2-PAF1-6HA
|
Genotype |
|
|
SPII media
|
Growth condition |
|
|
GAL-ABF1 overexpression transg...
|
Genotype |
|
|
Monosomal_RNA
|
Material type |
|
|
Total_RNA
|
Material type |
|
|
Abf1-1 hypomorph / GAL-ABF1 ov...
|
Genotype |
|
|
Ethanol-limiting medium
|
Growth condition |
|
|
Glucose-limiting medium
|
Growth condition |
|
|
Dessication
|
Growth condition |
|
|
YPD media
|
Growth condition |
|
|
Paf1 null mutant
|
Genotype |
|
|
Respiratory deficient
|
Clinical info |
|
|
Nitrogen limited
|
Growth condition |
|
|
Carbon limited
|
Growth condition |
|
|
Ctr9 null mutant
|
Genotype |
|
|
Methyl methanesulfonate
|
Compound treatment |
|
|
25 degree_C
|
Temperature |
|
|
3 days in YPD (control)
|
Growth condition |
|
|
3 days in YPD + 2% glucose for...
|
Growth condition |
|
|
|
|
|
Processing time: 0.279 secs.